Hormonal regulation of tumor suppressor proteins in breast cancer cells (Q43625322)

25 November 2017

Hormonal regulation of tumor suppressor proteins in breast cancer cells (English)

1 reference

25 November 2017

Moudgil VK

1

1 reference

25 November 2017

Dinda S

2

1 reference

25 November 2017

Khattree N

3

1 reference

25 November 2017

Jhanwar S

4

1 reference

25 November 2017

Alban P

5

1 reference

25 November 2017

Hurd C

6

1 reference

25 November 2017

1 January 2001

1 reference

The Journal of Steroid Biochemistry and Molecular Biology

25 November 2017

1 reference

25 November 2017

76

1 reference

25 November 2017

1-5

1 reference

25 November 2017

105-117

1 reference

Transfection of human estrogen receptor (ER) cDNA into ER-negative mammalian cell lines

25 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2800%2900151-5

7 January 2021

Construction of cell lines that express high levels of the human estrogen receptor and are killed by estrogens

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2800%2900151-5

7 January 2021

Measurement of steroid hormone receptors in breast cancer patients on tamoxifen

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2800%2900151-5

7 January 2021

Acquired tamoxifen resistance: correlation with reduced breast tumor levels of tamoxifen and isomerization of trans-4-hydroxytamoxifen.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2800%2900151-5

7 January 2021

How do breast cancers become hormone resistant?

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2800%2900151-5

7 January 2021

Hormonal regulation of the p53 tumor suppressor protein in T47D human breast carcinoma cell line

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2800%2900151-5

7 January 2021

p53: at the crossroads of molecular carcinogenesis and risk assessment

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2800%2900151-5

7 January 2021

Mutations in the p53 gene occur in diverse human tumour types

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2800%2900151-5

7 January 2021

Mutations in p53 as potential molecular markers for human breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2800%2900151-5

7 January 2021

p53 gene mutations and steroid receptor status in breast cancer. Clinicopathologic correlations and prognostic assessment

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2800%2900151-5

7 January 2021

The retinoblastoma susceptibility gene encodes a nuclear phosphoprotein associated with DNA binding activity

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2800%2900151-5

7 January 2021

Cytostatic gene therapy for vascular proliferative disorders with a constitutively active form of the retinoblastoma gene product

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2800%2900151-5

7 January 2021

Cell cycle-dependent regulation of phosphorylation of the human retinoblastoma gene product

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2800%2900151-5

7 January 2021

The retinoblastoma-susceptibility gene product becomes phosphorylated in multiple stages during cell cycle entry and progression

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2800%2900151-5

7 January 2021

Differential regulation of retinoblastoma protein function by specific Cdk phosphorylation sites

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2800%2900151-5

7 January 2021

Convergence of mitogenic signalling cascades from diverse classes of receptors at the cyclin D-cyclin-dependent kinase-pRb-controlled G1 checkpoint

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2800%2900151-5

7 January 2021

Regulation of tumor suppressor proteins, p53 and retinoblastoma, by estrogen and antiestrogens in breast cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2800%2900151-5

7 January 2021

Estrogen-dependent cyclin E-cdk2 activation through p21 redistribution

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2800%2900151-5

7 January 2021

Estrogen-induced activation of Cdk4 and Cdk2 during G1-S phase progression is accompanied by increased cyclin D1 expression and decreased cyclin-dependent kinase inhibitor association with cyclin E-Cdk2.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2800%2900151-5

7 January 2021

The retinoblastoma protein and cell cycle control

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2800%2900151-5

7 January 2021

Effects of antiprogestins on the rate of proliferation of breast cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2800%2900151-5

7 January 2021

Immunologic analysis of human breast cancer progesterone receptors. 1. Immunoaffinity purification of transformed receptors and production of monoclonal antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2800%2900151-5

7 January 2021

Human p53 oncogene contains one promoter upstream of exon 1 and a second, stronger promoter within intron 1.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2800%2900151-5

7 January 2021

Transactivation of the human p53 tumor suppressor gene by c-Myc/Max contributes to elevated mutant p53 expression in some tumors.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2800%2900151-5

7 January 2021

Taxol and cisplatin inhibit proliferation of T47D human breast cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2800%2900151-5

7 January 2021

Estrogen-dependent and independent activation of the P1 promoter of the p53 gene in transiently transfected breast cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2800%2900151-5

7 January 2021

Crystal structure of a p53 tumor suppressor-DNA complex: understanding tumorigenic mutations

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2800%2900151-5

7 January 2021

Growth regulation of a cellular tumour antigen, p53, in nontransformed cells

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2800%2900151-5

7 January 2021

Agonist and antagonist-induced qualitative and quantitative alterations of progesterone receptor from breast cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2800%2900151-5

7 January 2021

Hormone-induced progesterone receptor phosphorylation consists of sequential DNA-independent and DNA-dependent stages: analysis with zinc finger mutants and the progesterone antagonist ZK98299.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2800%2900151-5

7 January 2021

Multiple Human Progesterone Receptor Messenger Ribonucleic Acids and Their Autoregulation by Progestin Agonists and Antagonists in Breast Cancer Cells

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2800%2900151-5

7 January 2021

Transcriptional repression of p53 by human T-cell leukemia virus type I Tax protein

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2800%2900151-5

7 January 2021

A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasia

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2800%2900151-5

7 January 2021

Tumor suppressor p53 is a direct transcriptional activator of the human bax gene

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2800%2900151-5

7 January 2021

Identification of p53 as a sequence-specific DNA-binding protein

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2800%2900151-5

7 January 2021

Regulation of the specific DNA binding function of p53

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2800%2900151-5

7 January 2021

Proapoptotic effects of antiestrogens, progestins and androgen in breast cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FS0960-0760%2800%2900151-5

7 January 2021

10.1016/S0960-0760(00)00151-5

Identifiers

DOI

1 reference

25 November 2017

1 reference